HomeCompareFMZNF vs JNJ

FMZNF vs JNJ: Dividend Comparison 2026

FMZNF yields 625.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FMZNF wins by $359450.78M in total portfolio value
10 years
FMZNF
FMZNF
● Live price
625.00%
Share price
$0.32
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$359450.81M
Annual income
$273,399,800,572.91
Full FMZNF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — FMZNF vs JNJ

📍 FMZNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFMZNFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FMZNF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FMZNF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FMZNF
Annual income on $10K today (after 15% tax)
$53,125.00/yr
After 10yr DRIP, annual income (after tax)
$232,389,830,486.97/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, FMZNF beats the other by $232,389,826,500.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FMZNF + JNJ for your $10,000?

FMZNF: 50%JNJ: 50%
100% JNJ50/50100% FMZNF
Portfolio after 10yr
$179725.42M
Annual income
$136,699,902,631.15/yr
Blended yield
76.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FMZNF
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$0.72
+125.0% upside vs current
Range: $0.72 — $0.72
Altman Z
0.6
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FMZNF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFMZNFJNJ
Forward yield625.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$359450.81M$30.3K
Annual income after 10y$273,399,800,572.91$4,689.40
Total dividends collected$352328.39M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$0.72$228.73

Year-by-year: FMZNF vs JNJ ($10,000, DRIP)

YearFMZNF PortfolioFMZNF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$73,200$62,500.00$10,592$272.30+$62.6KFMZNF
2$505,894$427,570.09$11,289$357.73+$494.6KFMZNF
3$3,302,979$2,761,671.84$12,123$472.89+$3.29MFMZNF
4$20,385,527$16,851,339.68$13,141$629.86+$20.37MFMZNF
5$119,012,643$97,200,129.44$14,408$846.81+$119.00MFMZNF
6$657,683,338$530,339,810.29$16,021$1,151.60+$657.67MFMZNF
7$3,442,734,786$2,739,013,613.82$18,122$1,588.22+$3442.72MFMZNF
8$17,083,489,966$13,399,763,745.21$20,930$2,228.20+$17083.47MFMZNF
9$80,421,501,126$62,142,166,862.30$24,792$3,191.91+$80421.48MFMZNF
10$359,450,806,778$273,399,800,572.91$30,274$4,689.40+$359450.78MFMZNF

FMZNF vs JNJ: Complete Analysis 2026

FMZNFStock

Qoria Limited markets, distributes, and sells cyber safety products and services. It offers Family Zone platform that delivers cyber safety settings, advice, and support to parents and schools across various networks and devices to keep children safe at home and school, as well as permits telecommunication service providers and device manufacturers to embed cyber safety practices into their offerings. The company also provides classroom management solutions. It offers hot spotting, VPN, and mobile solutions for families and schools, IT companies, educators, residential managers, and pastoral care organizations. It serves in Australia, New Zealand, the United Kingdom, the United States, Europe, Canada, Asia, and internationally. The company was formerly known as Family Zone Cyber Safety Limited and changed its name to Qoria Limited in May 2023. Qoria Limited was incorporated in 2014 and is based in Perth, Australia.

Full FMZNF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this FMZNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FMZNF vs SCHDFMZNF vs JEPIFMZNF vs OFMZNF vs KOFMZNF vs MAINFMZNF vs ABBVFMZNF vs MRKFMZNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.